In one study, the combined Ig1-Ig2 domains competitively blocked binding of MuSK-IgG to full-length MuSK in nine MuSK-MG patients, and Ig3-C6-Ig4 additionally showed similar competition in five of the nine patients33. The gene discussed is MUSK; the disease is myasthenia gravis.